ClearPoint Neuro (CLPT) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 5.69% |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | 47.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.89% |
| Mar 31, 2026 | 33.49% |
| Dec 31, 2025 | 30.72% |
| Sep 30, 2025 | 24.72% |
| Jun 30, 2025 | 30.68% |
| Mar 31, 2025 | 62.06% |
| Dec 31, 2024 | 44.35% |
| Sep 30, 2024 | 25.09% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | 41.94% |
| Dec 31, 2023 | 72.33% |
| Sep 30, 2023 | 115.42% |
| Jun 30, 2023 | 97.39% |
| Mar 31, 2023 | 33.85% |
| Dec 31, 2022 | 49.54% |
| Sep 30, 2022 | 39.78% |
| Jun 30, 2022 | 97.42% |
| Mar 31, 2022 | 142.81% |
| Dec 31, 2021 | 68.97% |
| Sep 30, 2021 | 37.59% |